Impact of CD34+ Graft Cell Dose on Outcomes after Haploidentical Bone Marrow Transplantation with Post-Transplant

Moazzam Shahzad1, Muhammad Kashif Amin2, Haritha Gandicheruvu3

  • 1Division of Hematology and Oncology, H Lee Moffitt Cancer Center, University of South Florida, Tampa, Florida; Mikael Rayaan Foundation Global Transplantation and Cellular Therapy Consortium, Kansas City, Kansas.

Abstract

No abstract available in PubMed .